TLSA (Tiziana Life Sciences) OCF Yield %: -8.97 (As of Jun. 25, 2026)


TLSA Tiziana Life Sciences Ltd TLSA
30 GF Score
Price $1.13
! 2 Warning Signs
View Full Analysis

What is Tiziana Life Sciences OCF Yield %?

Tiziana Life Sciences TLSA +0.45% 30 OCF Yield % is -8.97 as of Jun. 25, 2026. GuruFocus rates TLSA with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 1,419 Biotechnology companies, Tiziana Life Sciences ranks worse than 51.59% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Tiziana Life Sciences's Trailing 12-Month Cash Flow from Operations is $-12.85 Mil, and Market Cap is $143.17 Mil. Therefore, Tiziana Life Sciences's OCF Yield % for today is -8.97%.

The historical rank and industry rank for Tiziana Life Sciences's OCF Yield % or its related term are showing as below:

TLSA' s OCF Yield % Range Over the Past 10 Years
Min: -9.09   Med: 0   Max: -8.75
Current: -8.97


During the past 13 years, the highest OCF Yield % of Tiziana Life Sciences was -8.75%. The lowest was -9.09%. And the median was %.

TLSA's OCF Yield % is ranked worse than
51.59% of 1419 companies
in the Biotechnology industry
Industry Median: -8.46 vs TLSA: -8.97

Tiziana Life Sciences's OCF Margin % for the quarter that ended in Dec. 2025 was %.


Tiziana Life Sciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Tiziana Life Sciences OCF Yield % Related Terms


Tiziana Life Sciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Tiziana Life Sciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tiziana Life Sciences OCF Yield % Chart

Tiziana Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.16 -32.58 -27.61 -1.97 -7.15

Tiziana Life Sciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.15 0.85 -4.96 -7.27 -6.71

TLSA vs DTIL, MIST, EQ: OCF Yield % Comparison

For the Biotechnology subindustry, Tiziana Life Sciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tiziana Life Sciences OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tiziana Life Sciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Tiziana Life Sciences's OCF Yield % falls into.


TLSA
30GF Score
Tiziana Life Sciences Ltd TLSA
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tiziana Life Sciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Tiziana Life Sciences's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-12.847 / 179.55543
=-7.15%

Tiziana Life Sciences's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-6.024 * 2 / 179.55543
=-6.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -8.97 mean?
Tiziana Life Sciences (TLSA) has a OCF Yield % of -8.97 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Tiziana Life Sciences and its competitors. According to the industry distribution chart, Tiziana Life Sciences ranks #732 out of 1419 companies in the Biotechnology industry, placing it in the top 51.6%.
Is Tiziana Life Sciences' OCF Yield % too high?
Tiziana Life Sciences' current OCF Yield % is -8.97. Based on the distribution chart, Tiziana Life Sciences ranks #732 out of 1419 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Tiziana Life Sciences has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Tiziana Life Sciences' OCF Yield % compare to DTIL and MIST?
According to the Biotechnology industry distribution chart, Tiziana Life Sciences ranks #732 out of 1419 companies for OCF Yield %. This places Tiziana Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Tiziana Life Sciences and its competitors. Tiziana Life Sciences's current OCF Yield % is -8.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tiziana Life Sciences stock overvalued right now?
Tiziana Life Sciences (TLSA) has a current OCF Yield % of -8.97. The current OCF Yield % is -8.97. Tiziana Life Sciences' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Tiziana Life Sciences (TLSA), the current OCF Yield % is -8.97 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tiziana Life Sciences Business Description

Other Exchanges 0RP:Germany
Address 2 Church Street, Clarendon House, Hamilton, BMU, HM 11
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
30GF Score

Get the complete analysis for TLSA

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price